# Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/padeliporfin-vascular-targeted-photodynamic-therapy-versus-active-surveillance/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Abdel-Rahmène Azzouzi,S. Vincendeau,Éric Barret,Antony Cicco,F. Kleinclauss,Henk G. van der Poel,Christian G. Stief,Jens Rassweiler,Georg Salomon,Eduardo Solsona,Antonio Alcaraz,Teuvo T. L. Tammela,Derek J. Rosario,F. Gómez-Veiga,Göran Ahlgren,Fawzi Benzaghou,B. Gaillac,Billy Amzal,F.M.J. Debruyne,Gaëlle Fromont,Christian Gratzke,Mark Emberton |
| Citations | 332 |
| DOI | 10.1016/s1470-2045(16)30661-1 |
| Fields | Engineering,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2566433825 |
| PMID | 28007457 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Christian Gratzke](https://scholariq.org/researchers/christian-gratzke/)
- [Gaëlle Fromont](https://scholariq.org/researchers/gaelle-fromont/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Photodynamic Therapy Research Studies](https://scholariq.org/topics/photodynamic-therapy-research-studies/)

## Paper topics

- [Photodynamic Therapy Research Studies](https://scholariq.org/topics/photodynamic-therapy-research-studies/)
- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)
- [Skin Protection and Aging](https://scholariq.org/topics/skin-protection-and-aging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.